Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 13.380 | 13.380 | 0.000 |
Shares | 86.820 | 86.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.196 | 21.169 |
Price to Book | 2.953 | 2.532 |
Price to Sales | 3.425 | 2.940 |
Price to Cash Flow | 14.557 | 12.483 |
Dividend Yield | 1.753 | 2.224 |
5 Years Earnings Growth | 15.316 | 11.690 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 94.780 | 97.348 |
Consumer Cyclical | 2.640 | 0.953 |
Industrials | 2.580 | 0.866 |
Number of long holdings: 32
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kelun Pharm A | CNE100000PW7 | 7.77 | 28.36 | -0.21% | |
Jiangsu Hengrui | CNE0000014W7 | 7.25 | 44.05 | -0.86% | |
Nhwa Pharma A | CNE100000CG8 | 6.65 | 22.42 | -2.52% | |
SonoScape Medical | CNE100002P91 | 6.62 | 28.40 | +0.18% | |
Humanwell Healthcare | CNE000000QW6 | 6.53 | 22.22 | -1.11% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 6.06 | 235.33 | +2.60% | |
Beigene | CNE100005XT6 | 4.79 | 188.66 | -0.79% | |
iRay Technology | CNE1000042V8 | 4.71 | 104.63 | -1.80% | |
Aier Eye Hospital Group | CNE100000GR6 | 4.62 | 12.51 | +1.71% | |
Imeik | CNE100004868 | 3.46 | 173.00 | +0.98% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhonghai High Quality Growth | 1.09B | -1.43 | -15.29 | 4.49 | ||
Zhonghai Energy | 974.45M | -20.64 | -24.90 | 0.46 | ||
Zhonghai Renew Energy DynamicMix | 822.95M | -10.19 | -19.88 | 4.72 | ||
Zhonghai Medical Health Ids SelA | 399.13M | -19.09 | -17.01 | 5.97 | ||
Zhonghai Medical Health Ids SelC | 399.13M | -19.95 | -17.84 | 5.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review